Company Quick10K Filing
Ambev
20-F 2020-12-31 Filed 2021-03-22
20-F 2019-12-31 Filed 2020-03-24
20-F 2018-12-31 Filed 2019-03-22
20-F 2017-12-31 Filed 2018-03-19
20-F 2016-12-31 Filed 2017-03-22
20-F 2015-12-31 Filed 2016-03-14
20-F 2014-12-31 Filed 2015-03-25
20-F 2013-12-31 Filed 2014-03-25

Ambev Financials

ABEV Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-31
Cash4,5374,9613,5973,7362,2033,2143,099
Accounts Receivable1,2071,2781,1211,1251,1791,3661,317
Inventory1,2281,2191,2621,1711,1741,3391,458
PP&E6,0836,0225,8245,1685,1726,4195,842
Assets30,48729,70726,69324,34822,63727,40725,843
Accounts Payable3,2983,4733,2503,2252,9993,7293,828
Long-Term Debt1,5451,2499709721,4571,4041,108
Liabilities12,10110,69010,54410,75810,04112,66210,330
Stockholders' Equity18,38619,01716,14913,59012,59614,74515,513
Income Statement ($MM)2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-31
Revenue15,91415,08414,09012,61412,31314,84913,562
Cost of Revenue5,1984,9764,7414,3374,5035,5895,197
Gross Profit10,71710,1089,3488,2787,8109,2608,365
R&D0000000
SG&A2,5292,3702,2692,0592,1852,5522,183
Tax1,1461,067742981851,565479
Net Income5,1254,9024,5743,4773,5332,4143,064
Cash Flow ($MM)2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-31
Cash Operating7,0156,5855,8816,8294,7805,6614,953
Cash Investing-2,803-1,639-1,764-1,619-1,592-953-992
Cash Financing-3,834-4,088-4,863-4,139-3,144-4,108-3,687